Fischer Medical ties up with Tech Avant-Garde for student healthcare services, shares up nearly 3%

In a filing to the stock exchanges on July 9, the company said that it has signed a Memorandum of Understanding (MoU) with Tech Avant-Garde (TAG), an innovative educational solutions provider, to drive holistic healthcare of students.

“This strategic partnership aims to drive holistic healthcare of students and their connected communities to enable a healthier and more conducive learning environment,” the company said in a release.

Fischer MV (formerly known as Fischer Chemic Ltd) is dedicated to transforming the healthcare landscape through advanced, affordable, and accessible medical diagnostic and imaging technologies, by leveraging cutting-edge innovations and AI-powered software solutions in healthcare, the company informed the bourses.

As the first company to indigenously manufacture high-quality Magnetic Resonance Imaging (MRI) systems in India, expanding into children's healthcare with TAG fits the company’s mission to support India’s education system. The company aims to promote long-term health awareness and preventive care for a healthier youth generation.

Fischer MV-TAG collaboration will start with screening students through Fischer MV’s Flynn Health Kiosk, a health screening machine that conducts a comprehensive diagnostic of over 60 clinical vital signs parameters within minutes. Eye health, audiology, oral health, mental health, and lung and respiratory health checks will also be implemented in phases, the company said.

Fischer MV-TAG collaboration will not only improve individual health outcomes but also contribute to the broader goal of enhancing public health infrastructure in India, according to the company.

Shares of Fischer Medical Venture Ltd opened at ₹600 apiece on the BSE and rallied as much as 2.8% to hit an intraday high of ₹616.85 apiece.

However, the stock pared early gains to trade at ₹601.2 apiece, down 0.96%, on the BSE at 2:20 pm.